On 10 September, Swiss 3PL Kuehne + Nagel (K+N) announced that “with the opening of airside pharma & healthcare hubs in Brussels, Belgium, and Johannesburg, South Africa,” it “adds two strategic elements to its global GxP-certified network of temperature-controlled facilities for the distribution of vaccines and other pharma & healthcare products.”
This in a world where vaccine prototypes may or may not work and where air is tight and must be …
The post Snapshot: In Kuehne + Nagel we trust...